日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical relevance of partial HPV genotyping in cervical cancer screening

部分HPV基因分型在宫颈癌筛查中的临床意义

Leino, Aarno; Numminen, Eero; Kares, Saara; Meriö, Markus; Kotaniemi-Talonen, Laura; Kholová, Ivana; Louvanto, Karolina

The quality of life of frequently vs. infrequently screened HPV vaccinated women

频繁接受HPV筛查与不频繁接受HPV筛查的接种过HPV疫苗的女性的生活质量比较

Taavela, Kaisa; Eriksson, Tiina; Huhtala, Heini; Bly, Anne; Harjula, Katja; Heikkilä, Kaisa; Hokkanen, Mari; Nummela, Mervi; Kotaniemi-Talonen, Laura; Lehtinen, Matti; Louvanto, Karolina

Logics and Agency in Public Management Research

公共管理研究中的逻辑与能动性

Shuman, Eric; Hasan-Aslih, Siwar; van Zomeren, Martijn; Saguy, Tamar; Halperin, Eran; Kinder, Tony; Stenvall, Jari; Talonen, Antti

Long-term risk of cancer among the first-degree relatives of epithelial ovarian cancer patients: A cohort study with 48 years of follow up

上皮性卵巢癌患者一级亲属的长期癌症风险:一项长达48年的随访队列研究

Kotaniemi-Talonen, Laura; Pukkala, Eero; Aittomäki, Kristiina; Auranen, Annika

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme

在采用细胞学分流的HPV DNA初筛中,宫颈癌、重度上皮内瘤变和原位腺癌的发生率:一项在有组织的筛查计划中进行的随机研究

Anttila, Ahti; Kotaniemi-Talonen, Laura; Leinonen, Maarit; Hakama, Matti; Laurila, Pekka; Tarkkanen, Jussi; Malila, Nea; Nieminen, Pekka

Alternative technologies in cervical cancer screening: a randomised evaluation trial

宫颈癌筛查替代技术:一项随机评估试验

Anttila, Ahti; Hakama, Matti; Kotaniemi-Talonen, Laura; Nieminen, Pekka